For researchers undertaking preliminary or exploratory work, smaller quantities may be appropriate
Most controlled trials show that you can lose as much as 6% of your body weight in one month after starting the Semaglutide treatment
reports participation on an advisory board or data monitoring board for Amgen, Boehringer Ingelheim, Currax, Structure Therapeutics and Regeneron
In December 2024, the FDA approved tirzepatide (Zepbound) for moderate-to-severe obstructive sleep apnea in adults with obesity, the first pharmacologic approval for that indication
This review will highlight the process of therapeutic clinical trial design, challenges in clinical trial recruitment, metabolic and antifibrotic agents under investigation, and an overview of the future landscape of pharmacologic design once initial agents are approved
How does this align with the medical literature and what I have seen in my 12 years of prescribing these medications for people with diabetes